Thema
Editorial
3.259
Comment
2.636
EC 3.4.21.77
136
Prostate-Specific Antigen
136
Biomarkers, Tumor
53
3XMK78S47O
31
Testosterone
31
Antineoplastic Agents
29
BCG Vaccine
28
Anti-Bacterial Agents
26
Androgen Antagonists
22
Biomarkers
19
Comparative Study
19
Adjuvants, Immunologic
15
Research Support, N.I.H., Extramural
15
Muscarinic Antagonists
14
Antigens, Neoplasm
13
Research Support, Non-U.S. Gov't
13
9004-61-9
11
Dextrans
11
Hyaluronic Acid
11
5-alpha Reductase Inhibitors
10
Androgens
10
Botulinum Toxins, Type A
10
DNA, Neoplasm
10
EC 3.4.24.69
10
Receptors, Androgen
10
57GNO57U7G
9
Antidiuretic Agents
9
Benzhydryl Compounds
9
Finasteride
9
33515-09-2
8
Adrenergic alpha-1 Receptor Antagonists
8
Cisplatin
8
Deamino Arginine Vasopressin
8
ENR1LLB0FP
8
Gonadotropin-Releasing Hormone
8
Mandelic Acids
8
Q20Q21Q62J
8
Sulfonamides
8
50SG953SK6
7
Cholinergic Antagonists
7
EC 2.7.10.1
7
Hydroxymethylglutaryl-CoA Reductase Inhibitors
7
Mitomycin
7
dextranomer-hyaluronic acid copolymer
7
prostatic neoplasms
7
2612HC57YE
6
33RU150WUN
6
5T619TQR3R
6
mehr ...